New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
06:29 EDTOPHT, NVSOphthotech price target raised to $51 from $40 at JPMorgan
JPMorgan raised its price target for Ophthotech (OPHT) shares to $51 citing strong terms for the company's out-licensing agreement with Novartis (NVS) for Fovista. The firm reiterates an Overweight rating on the stock.
News For OPHT;NVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
08:57 EDTNVSGlaxoSmithKline return of transaction net proceeds to be reduced to GBP1B
Subscribe for More Information
May 4, 2015
07:35 EDTNVSNewYorkBio to hold a conference
Subscribe for More Information
May 1, 2015
15:14 EDTNVSExpress Scripts in settlement pact related to alleged Novartis kickbacks
Accredo Health, a wholly-owned subsidiary of Express Scripts (ESRX), entered a settlement and dismissal agreement with United States Attorney for the Southern District of New York, Preet Bharara, related to Accredo's alleged involvement in Novartis's (NVS) alleged participation in a kickback scheme involving Exjade, according to a court filing. In settlement of the United States' claims against Accredo in this action, Accredo shall pay to the United States a sum just over $45M, according to the court filing. A recent filing with the SEC noted that a total of $60M was set aside by Express Scripts to resolve the allegations with the federal government and all 50 states and a company spokesman confirmed the settlement involves $60M, according to The Wall Street Journal. Reference Link
07:56 EDTOPHTOphthotech employees win $58M lottery prize, NBC reports
Subscribe for More Information
07:43 EDTNVSExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 27, 2015
10:30 EDTNVSNovartis says Phase III Arzerra study met primary endpoint
Subscribe for More Information
06:19 EDTNVSPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 23, 2015
09:52 EDTNVSEli Lilly sees at least $200M in savings from Novartis Animal Health acquisition
05:25 EDTNVSNovartis backs FY15 revenue guidance of growth in mid-single digits
Subscribe for More Information
05:22 EDTNVSNovartis reports Q1 Core EPS $1.33, consensus $1.10
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use